An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits secretion from alveolar epithelial type II cells

Cell Signal. 1998 Feb;10(2):137-42. doi: 10.1016/s0898-6568(97)00101-0.

Abstract

We investigated the effect of translational suppression of m-calpain on [3H]-phosphatidylcholine (PC) secretion utilising an antisense oligodexoyribonucleotide (oligo) directed against mRNA encoding m-calpain catalytic subunit. Two types of oligo, sense (S) and antisense (AS), to a portion of exon 12 of rat m-calpain catalytic subunit mRNA were tested. Constitutive secretion was decreased by 23% by AS-oligo (1 microM) treatment, while S-oligo (1 microM) had no effect. TPA-stimulated secretion was inhibited about 50-60% by AS-oligo (1-3 microM) and the inhibition was concentration-dependent, while S-oligo (1 microM) only inhibited about 10% of TPA-stimulated secretion. Northern and Western blot analyses revealed that the AS-oligo treatment reduced m-calpain mRNA and protein levels by 32% and 78%, respectively. The data indicate that antisense strategy is effective in suppressing calpain expression and type II cell secretion.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blotting, Northern
  • Blotting, Southern
  • Calpain / genetics
  • Calpain / physiology*
  • Cells, Cultured
  • Gene Expression Regulation / drug effects
  • Male
  • Oligonucleotides, Antisense / pharmacology
  • Phosphatidylcholines / metabolism
  • Pulmonary Alveoli / cytology
  • Pulmonary Alveoli / drug effects
  • Pulmonary Alveoli / metabolism*
  • RNA, Antisense / pharmacology
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Oligonucleotides, Antisense
  • Phosphatidylcholines
  • RNA, Antisense
  • RNA, Messenger
  • Calpain